• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should Nonischemic CRT Candidates Receive CRT-P or CRT-D?

作者信息

Levy Wayne C

机构信息

Division of Cardiology, University of Washington, Seattle, Washington.

出版信息

J Am Coll Cardiol. 2017 Apr 4;69(13):1679-1682. doi: 10.1016/j.jacc.2017.01.044.

DOI:10.1016/j.jacc.2017.01.044
PMID:28359512
Abstract
摘要

相似文献

1
Should Nonischemic CRT Candidates Receive CRT-P or CRT-D?非缺血性心脏再同步化治疗候选者应接受心脏再同步化治疗-起搏器（CRT-P）还是心脏再同步化治疗-除颤器（CRT-D）？
J Am Coll Cardiol. 2017 Apr 4;69(13):1679-1682. doi: 10.1016/j.jacc.2017.01.044.
2
Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.MADIT-CRT 中的心脏再同步治疗的心脏和非心脏死亡率的风险因素及影响。
Europace. 2015 Dec;17(12):1816-22. doi: 10.1093/europace/euv201. Epub 2015 Jun 11.
3
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).心脏再同步治疗除颤器与植入式心脏复律除颤器患者中，间歇性房性快速心律失常对心力衰竭或死亡的影响：MADIT-CRT 亚研究（多中心自动除颤器植入试验与心脏再同步治疗）。
J Am Coll Cardiol. 2014 Apr 1;63(12):1190-1197. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11.
4
Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.由于起搏诱导性心肌病而升级为心脏再同步治疗的患者发生危及生命的室性心律失常的风险较低：一项长期死因分析。
Europace. 2018 Jan 1;20(1):89-96. doi: 10.1093/europace/euw321.
5
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.采用一套新型检测算法减少心脏再同步治疗除颤器治疗的心力衰竭患者不适当的抗心动过速起搏治疗和电击：前瞻性数据库的历史对照研究
Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420. Epub 2016 Jan 29.
6
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.心力衰竭合并心房颤动患者心脏再同步治疗的比较效果：来自国家心血管数据注册中心植入式心律转复除颤器注册研究的结果
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.002324.
7
PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.PR 间期可预测非左束支传导阻滞患者的临床反应：多中心自动除颤器植入试验-心脏再同步治疗亚研究。
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):645-51. doi: 10.1161/CIRCEP.113.001299. Epub 2014 Jun 24.
8
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.心脏再同步治疗除颤器与心脏再同步治疗起搏器相比，可改善 I 类心脏再同步治疗适应证患者的长期生存率：来自 Contak 意大利注册研究的数据。
Europace. 2013 Sep;15(9):1273-9. doi: 10.1093/europace/eut032. Epub 2013 Feb 24.
9
Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.与仅接受植入式心律转复除颤器（ICD）治疗的窄QRS波心力衰竭患者相比，接受心脏再同步化治疗（CRT）联合ICD治疗的宽QRS波心力衰竭患者长期总体死亡率降低。
Europace. 2016 Sep;18(9):1374-82. doi: 10.1093/europace/euv347. Epub 2015 Nov 26.
10
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.

引用本文的文献

1
The Role of ARNI in Enhancing Outcomes of Cardiac Resynchronization Therapy: A Comprehensive Review.ARNI在改善心脏再同步治疗结局中的作用：一项综述
J Clin Med. 2025 Apr 16;14(8):2743. doi: 10.3390/jcm14082743.
2
Mapping the research trends and hot topics of ventricular arrhythmia: A bibliometric analysis from 2001 to 2020.绘制室性心律失常的研究趋势与热点：一项2001年至2020年的文献计量分析
Front Cardiovasc Med. 2022 Oct 20;9:856695. doi: 10.3389/fcvm.2022.856695. eCollection 2022.
3
Is there a benefit of ICD treatment in patients with persistent severely reduced systolic left ventricular function after TAVI?
经 TAVI 治疗后持续性严重左心室收缩功能减退的患者中，ICD 治疗是否有益？
Clin Res Cardiol. 2022 May;111(5):492-501. doi: 10.1007/s00392-021-01826-x. Epub 2021 Mar 23.
4
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction?血管紧张素受体脑啡肽酶抑制剂（ARNI）的应用是否会减少射血分数降低的心力衰竭患者对器械治疗的需求？
Egypt Heart J. 2021 Mar 16;73(1):26. doi: 10.1186/s43044-021-00152-x.
5
Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use.是时候震撼这个系统了：超越目前用于一级预防植入式心脏复律除颤器使用的范式。
J Am Heart Assoc. 2020 Mar 3;9(5):e015139. doi: 10.1161/JAHA.119.015139. Epub 2020 Feb 24.